Lavender Alternatives Compared
| Lavender | Mounjaro (tirzepatide) | Rybelsus (semaglutide) |
|
|---|
| Lavender | Mounjaro (tirzepatide) | Rybelsus (semaglutide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Used for Type 2 Diabetes, Anxiety, Diabetes - Type 1, Acne, Herbal Supplementation, Insomnia, Neuralgia, Upper Respiratory Tract Infection. Lavender may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Prescription only
Rybelsus (semaglutide) is an oral medicine that can be used as a first-line medication to improve blood sugar control in adults over the age of 18 with type 2 diabetes. It works by mimicking the... View more |
Related suggestions Type 2 Diabetes
|
|||||||
| More about Lavender | More about Mounjaro (tirzepatide) | More about Rybelsus (semaglutide) | ||||||||
| Ratings & Reviews | ||||||||||
|
Lavender has an average rating of 5.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Mounjaro has an average rating of 8.5 out of 10 from a total of 1460 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
Rybelsus has an average rating of 6.5 out of 10 from a total of 315 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Mounjaro side effects |
View all Rybelsus side effects |
|||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Mounjaro prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
|
N/A |
Other tirzepatide brands include: Zepbound | Other semaglutide brands include: Ozempic, Wegovy | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
N/A |
120 hours |
168 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Unknown
CSA Schedule is unknown. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category N
Not classified
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 416 drugs are known to interact with Mounjaro:
|
A total of 275 drugs are known to interact with Rybelsus:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| First Approval Date | ||||||||||
|
N/A |
N/A |
September 20, 2019 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.